Formulation and Characterization of Luliconazole Loaded Niosomal Gel

Authors

  • Jyoti Bala Patidar
  • Narendra Gehalot
  • Garvita Joshi
  • Vikas Jain

Keywords:

Luliconazole, niosomes, Span 60, Carbopol 934, topical gel, entrapment efficiency, sustained release

Abstract

Background: Luliconazole is an effective imidazole antifungal; however, its lipophilicity and poor aqueous solubility can limit topical performance and may require frequent application. Vesicular carriers such as niosomes can improve dermal localization and provide controlled release.

Objective: This study aimed to develop luliconazole-loaded niosomes using Span 60 and cholesterol by thin-film hydration, optimize vesicle composition, and incorporate the optimized dispersion into a Carbopol 934 gel for sustained topical delivery

Methods: Luliconazole was characterized by organoleptic examination, melting point and UV–Visible spectroscopy (λmax 296 nm), and preformulation studies included solubility profiling and FTIR-based compatibility. Eight niosomal batches (F1–F8) were prepared using chloroform:methanol (2:1) with rotary evaporation, hydration in PBS (pH 7.4), and probe sonication. Vesicle size, PDI and zeta potential were determined by DLS. Entrapment efficiency was evaluated by centrifugation and UV quantification of free drug. The optimized batch was incorporated into Carbopol 934 gel and evaluated for appearance, pH, viscosity, spreadability, drug content, in vitro drug release (Franz/dialysis) and stability

Results: Niosomes were obtained in the nanosize range (142.8–218.4 nm) with acceptable PDI (0.198–0.321) and negative zeta potential (−19.6 to −26.5 mV). Entrapment efficiency ranged from 58.32% to 82.34%, with batch F4 showing the best overall characteristics (142.8 ± 2.9 nm, PDI 0.198, −26.5 ± 1.3 mV, 82.34 ± 1.25%). The niosomal gel showed skin-compatible pH (6.01 ± 0.03), pseudoplastic rheology, high drug content (98.64 ± 0.51%) and sustained release compared with plain gel (12 h: 76.30% vs 98.76%).


Conclusion: Span 60 niosomal gel provided stable nanosized vesicles, high drug entrapment and sustained release, supporting its potential as an improved topical delivery system for luliconazole.



Downloads

Download data is not yet available.

References

[1] Charaka Samhita. ChikitsaSthana, Chapter 28, Verse 88-90. Varanasi: Chaukhamba Bharati Academy; Reprint 2019.

[2] Susruta Samhita. ChikitsaSthana, Chapter 5. Varanasi: Chaukhamba Orientalia; 2018.

[3] Dorsey ER, Sherer T, Okun MS, Bloem BR. The emerging evidence of the Parkinson pandemic. J Parkinsons Dis. 2018; 8 (s1):S3-8. https://doi.org/10.3233/JPD-181474

[4] GBD 2021 Nervous System Disorders Collaborators. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol. 2024; 23(4):344-81. https://doi.org/10.1016/S1474-4422(24)00038-3.

[5] World Health Organization. Depression and other common mental disorders: global health estimates [Internet]. Geneva: WHO; 2017 [cited 2025 Oct 30]. Available from: https://www.who.int/publications/i/item/depression-global-health-estimates El-Meshad AN, Mohsen AM. Enhanced topical delivery of antifungal drug using niosomes. Int J Pharm. 2016;515(1–2):639–648. doi:10.1016/j.ijpharm.2016.10.047

[6] Manosroi A, Wongtrakul P, Manosroi J. Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol. Colloids Surf B Biointerfaces. 2003;30(1–2):129–138. doi:10.1016/S0927-7765(03)00063-4

[7] Abdelbary A, AbouGhaly MHH. Design and optimization of topical niosomal gel of antifungal drug. AAPS PharmSciTech. 2015;16(4):857–874. doi:10.1208/s12249-015-0306-7

[8] Moghimipour E, Salimi A, Karami M. Niosomes as a carrier for topical delivery of diclofenac sodium. Drug Dev Ind Pharm. 2015;41(10):1684–1690. doi:10.3109/03639045.2014.987417

[9] Paolino D, Cosco D, Cilurzo F, Fresta M. Innovative drug delivery systems for the administration of antifungal drugs. J Control Release. 2012;162(1):1–12. doi:10.1016/j.jconrel.2012.06.012

[10] Chandra A, Sharma PK. Development and evaluation of antifungal niosomal gel for topical drug delivery. J Drug Deliv Sci Technol. 2020;56:101529.doi:10.1016/j.jddst.2020.101529

[11] Ruckmani K, Sankar V. Formulation and optimization of zidovudine niosomes. AAPS PharmSciTech. 2010;11(3):1119–1127.doi:10.1208/s12249-010-9474-1

[12] El-Laithy HM, Shoukry O, Mahran LG. Novel sugar esters proniosomes for transdermal delivery of vinpocetine. Int J Pharm. 2011;403(1–2):45–54.doi:10.1016/j.ijpharm.2010.10.033

[13] Rakesh S, Rana AC. Formulation and evaluation of antifungal niosomal gel. Int J Pharm Sci Nanotechnol. 2014;7(3):2614–2621.doi:10.37285/ijpsn.2014.7.3.6

[14] Nasr M, Mansour S, Mortada ND, Elshamy AA. Vesicular systems for topical delivery of antifungal drugs. Drug Dev Ind Pharm. 2008;34(12):1360–1368.doi:10.1080/03639040802144262

[15] Abdallah MH, Sammour OA, El-Ghamry HA. Preparation and in vitroevaluation of antifungal niosomal formulations. Pharm Dev Technol. 2013;18(3):647–655.doi:10.3109/10837450.2011.640682

[16] Yeo PL, Lim CL, Chye SM. Formulation of antifungal drug-loaded niosomes for enhanced topical delivery. Pharmaceutics. 2018;10(4):E186.doi:10.3390/pharmaceutics10040186

[17] Kaur IP, Garg A, Singla AK, Aggarwal D. Vesicular systems in ocular drug delivery. Int J Pharm. 2004;269(1):1–14.doi:10.1016/j.ijpharm.2003.09.016

[18] Elsayed MM, Abdallah OY, Naggar VF, Khalafallah NM. Lipid vesicles for skin delivery. Int J Pharm. 2007;332(1–2):1–16.doi:10.1016/j.ijpharm.2006.10.006

[19] Raval A, Patel MM. Preparation and characterization of niosomal gel for topical delivery. J Pharm Bioallied Sci. 2012;4(Suppl 1):S35–S40.doi:10.4103/0975-7406.94142

[20] Solanki AB, Parikh JR, Parikh RH. Formulation and optimization of niosomes for topical drug delivery. Drug Deliv Lett. 2010;1(1):16–24.doi:10.2174/2210303101001010016

[21] El-Ridy MS, Yehia SA, Mohsen AM. Niosomes as carriers for antifungal drugs. AAPS PharmSciTech. 2011;12(3):760–769.doi:10.1208/s12249-011-9645-3

[22] Subongkot T, Wonglertnirant N. Preparation and evaluation of antifungal niosomes. Asian J Pharm Sci. 2015;10(6):491–499.doi:10.1016/j.ajps.2015.04.003

[23] Kassem MA, El-Meshad AN, Fares AR. Enhanced topical delivery of antifungal agent via niosomal gel. Drug Dev Ind Pharm. 2017;43(12):1974–1984.doi:10.1080/03639045.2017.1357071

[24] Ammar HO, Ghorab MM, El-Nahhas SA, Kamel R. Proniosomes as carriers for transdermal delivery. Drug Dev Ind Pharm. 2011;37(1):1–11.doi:10.3109/03639045.2010.497281

Downloads

Published

2026-01-05

How to Cite

1.
Patidar JB, Gehalot N, Joshi G, Jain V. Formulation and Characterization of Luliconazole Loaded Niosomal Gel. J Neonatal Surg [Internet]. 2026 Jan. 5 [cited 2026 Jan. 20];14(33S):364-77. Available from: https://jneonatalsurg.com/index.php/jns/article/view/9828

Issue

Vol. 14 No. 33S (2025): Journal of Neonatal Surgery

Section

Original Article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  • Adapt — remix, transform, and build upon the material for any purpose, even commercially.

Terms:

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.